Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247820.RAw1U-oLx3xUlLj-waIZzdRMcTqJdQM_IxloK8YgegmlI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247820.RAw1U-oLx3xUlLj-waIZzdRMcTqJdQM_IxloK8YgegmlI130_assertion type Assertion NP1247820.RAw1U-oLx3xUlLj-waIZzdRMcTqJdQM_IxloK8YgegmlI130_head.
- NP1247820.RAw1U-oLx3xUlLj-waIZzdRMcTqJdQM_IxloK8YgegmlI130_assertion description "[Furthermore, we investigated whether stimulation of breast cancer cells with a B1R agonist would modify the cellular levels of KLK6, KLK10 and KLK11, three kallikrein-related peptidases with a still poorly-understood biological role in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247820.RAw1U-oLx3xUlLj-waIZzdRMcTqJdQM_IxloK8YgegmlI130_provenance.
- NP1247820.RAw1U-oLx3xUlLj-waIZzdRMcTqJdQM_IxloK8YgegmlI130_assertion evidence source_evidence_literature NP1247820.RAw1U-oLx3xUlLj-waIZzdRMcTqJdQM_IxloK8YgegmlI130_provenance.
- NP1247820.RAw1U-oLx3xUlLj-waIZzdRMcTqJdQM_IxloK8YgegmlI130_assertion SIO_000772 25503118 NP1247820.RAw1U-oLx3xUlLj-waIZzdRMcTqJdQM_IxloK8YgegmlI130_provenance.
- NP1247820.RAw1U-oLx3xUlLj-waIZzdRMcTqJdQM_IxloK8YgegmlI130_assertion wasDerivedFrom befree-2016 NP1247820.RAw1U-oLx3xUlLj-waIZzdRMcTqJdQM_IxloK8YgegmlI130_provenance.
- NP1247820.RAw1U-oLx3xUlLj-waIZzdRMcTqJdQM_IxloK8YgegmlI130_assertion wasGeneratedBy ECO_0000203 NP1247820.RAw1U-oLx3xUlLj-waIZzdRMcTqJdQM_IxloK8YgegmlI130_provenance.